You searched for "carcinoma"

204 results found

BSFPS Annual Meeting 2023 and Juniors Day

Haseem Raja, ST4 ENT Registrar at University Hospital North Midlands, and Edward Balai, ST5 ENT Registrar at Charing Cross Hospital. The British Society of Facial Plastic Surgery (BSFPS) Annual Meeting took place in the vibrant city of Manchester, with leading...

19th Annual National ENT Masterclass®

Miss Eleanor Crossley, Association of Otolaryngologists in Training (AOT) President and ENT Registrar, South London DeaneryDoncaster Royal Infirmary was again the home of the 19th International ENT Masterclass in January 2025. The three-day programme was packed with sub-specialists and delegates...

4th Irish Head and Neck Society Annual Conference 2025

Nadia Van Den Berg, ST4, Otolaryngology, Waterford University Hospital, Ireland. The 4th Annual Irish Head and Neck Society (IHNS) Conference was held in April with huge success, in the idyllic Lyrath Covention Centre with over 200 delegates in attendance. After...

OBITUARY: David Moffat (1948-2020)

David Moffat, one of the leading Otologists of his generation, died on 18 March in Addenbrooke’s Hospital in Cambridge, the hospital to which he had devoted his professional life. Having survived cancer of the prostate, he succumbed to a second...

World Congress on Thyroid Cancer 2023

The World Congress on Thyroid Cancer (WCTC) meets in London next month for the first time since 2019. More than 800 thyroid professionals will participate in a robust programme that includes the latest surgical technologies, RAI dedifferentiation advances and TKI-targeted...

American Thyroid Association Thyroid Cancer Management Guidelines: utilising risk stratification to optimise patient care

The steep rise in thyroid surgery around the globe, has led to the development of risk stratification to define the indications for surgery and the extent of surgery as well as adjuvant therapies for papillary carcinoma, to avoid over treatment....

The role of the maxillo-facial surgeon in the management of skull base malignancy

Whilst ablative surgery remains the principal treatment option for head and neck malignancy, the skull base is the last frontier. The complex anatomy, supreme functionality of the brain, and varied pathology provokes many a detailed discussion in the multidisciplinary team...

Destination unknown

We as doctors do not always know the answer. Associate Professor Jacqueline Allen guides us through the importance of acceptance of this uncertainty and its complex mental journey. She highlights that, as clinicians, we must embrace the unknown and be...

Patient initiated follow-up in head and neck cancer

Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...

Thyroid nodules – time for a rational imaging approach

“The more you know, the harder it is to take decisive action. Once you become informed, you start seeing complexities and shades of gray. You realize that nothing is as clear as it first appears. Ultimately, knowledge is paralyzing.” Calvin,...

Laryngeal papillomatosis

Laryngeal papillomatosis remains one of the most frustrating conditions seen by laryngologists. Sam Majumdar gives us an overview of the current science and clinical practice. Human papilloma virus is a small (> 8kb) double stranded DNA virus with approximately 200...

7th World Congress of IFHNOS

Francesca Gaino, Medical Resident, Department of Otorhinolaryngology - Head and Neck Surgery, Humanitas Research Hospital, Milan, Italy and Professor Hesham Negm, Cairo University, Egypt, Global Ambassador of ENT & Audiology News. The 7th World Congress of the International Federation of...